HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1614994Erstellt: 25. Oktober 2026
Lithium Hydroxide → 3-(Pyridin-3-yloxy)-4,5-dihydroisoxazole
https://huagongshe.com/reaction/1614994
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Lithium Hydroxide | HCID 3939 | — |
| Edukt | Tetrahydrofuran | HCID 8028 | — |
| Edukt | Methyl 5-hydroxypyridine-3-carboxylate | HCID 354317 | — |
| Edukt | 3-Bromo-4,5-dihydroisoxazole | HCID 21983498 | — |
| Lösungsmittel | Oxolane--water (1/1) | HCID 21881883 | — |
| Produkt | 3-(Pyridin-3-yloxy)-4,5-dihydroisoxazole | HCID 66818532 | — |
Reaktionsschritte
The enantiomers of 3-(pyridin-3-yloxy)-4,5-dihydroisoxazole III-74a and III-74b were prepared in 2 steps according to the following procedures: racemic 3-bromo 4,5-dihydroisoxazole III-66 was reacted with 5-hydroxynicotinic acid methyl ester using Method 5. The resulting ester (1.0 equiv) was dissolved in 1:1 tetrahydrofuran/water (0.06 M) and lithium hydroxide (8.0 equiv) was added. The reaction was allowed to stir at room temperature for 1 h after which point the tetrahydrofuran was removed under a stream of nitrogen and the remaining solution was acidified to pH<2 with 1N HCl to provide the racemic desired acid III-74 as a white solid which was isolated via vacuum filtration. These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M+H]+=395.5 m/z. Activity: A
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US08765735B2 |
|---|
| Quelldatensatz | uspto-grants-2014_07 |
|---|
| ORD ID | ord-f320e0728bc8497ab9a6ddbc698743d9 |
|---|
| Quellennotiz | uspto-grants-2014_07 |
|---|